Bibliography

Found 5 results
Filters: Author is Anastos, Kathryn  [Clear All Filters]
Journal Article
Williams DW, Byrd D, Rubin LH, Anastos K, Morgello S, Berman JW. CCR2 on CD14(+)CD16(+) monocytes is a biomarker of HIV-associated neurocognitive disorders. Neurol Neuroimmunol Neuroinflamm [Internet]. 2014 ;1(3):e36. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25340088
Veenstra M, Williams DW, Calderon TM, Anastos K, Morgello S, Berman JW. CXCR7 mediates CD14+CD16+ monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. Journal of Leukocyte Biology [Internet]. 2017 ;102. Available from: DOI: 10.1189/jlb.3HI0517-167R
Calderon TM, Williams DW, Lopez L, Eugenin EA, Cheney L, Gaskill PJ, Veenstra M, Anastos K, Morgello S, Berman JW. Dopamine Increases CD14CD16 Monocyte Transmigration across the Blood Brain Barrier: Implications for Substance Abuse and HIV Neuropathogenesis. J Neuroimmune Pharmacol [Internet]. 2017 ;12(2):353-370. Available from: https://www.ncbi.nlm.nih.gov/pubmed/28133717
Veenstra M, Williams DW, Calderon TM, Anastos K, Morgello S, Berman JW. Frontline Science: CXCR7 mediates CD14CD16 monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. J Leukoc Biol. 2017 ;102(5):1173-1185.
Williams DW, Anastos K, Morgello S, Berman JW. JAM-A and ALCAM are therapeutic targets to inhibit diapedesis across the BBB of CD14+CD16+ monocytes in HIV-infected individuals. J Leukoc Biol [Internet]. 2015 ;97(2):401-12. Available from: https://www.ncbi.nlm.nih.gov/pubmed/25420915